Okmeydani Hospital Istanbul Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2002
NCT00590278
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

OKMEYDANI RESEARCH HOSPITAL | Okmeydani Training and Research Hospital

Active Ingredients

Drugs in Phase 4 Trials (3)

clavulanate (Augmentin) (1 trial)

lactobacillus reuteri (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

Drugs in Phase 2 Trials (1)

Raltitrexed (Tomudex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 4)

Rectal Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4